Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,595.3
32.1 (1.25%)

 

  • STI Straits Times Index
    2,595.3
    32.1 (1.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,569.7
    13.1 (0.84%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,215.6
    -28.4 (-0.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,322.8
    3.6 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,272.3
    428.4 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,229.8
    -3.7 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 668.7M
  • Value: 632.7M
  • Rise: 210
  • Fall: 70
  • Unch: 528

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.026+0.008
Medtecs Intl1.570+0.160
QT Vascular0.008+0.001
ThaiBev0.610+0.010
Sembcorp Marine0.245-0.105
UMS1.170+0.090
Rex Intl0.184+0.002
Genting Sing0.725+0.020
IPS Securex0.117+0.005
YZJ Shipbldg SGD0.960+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALPHAMAB-B ALPHAMAB-B
Quotes 15 Minutes Delayed. Updated at 13 Aug 2020 11:36
Last (HKD): 15.920 Change: +0.720 High: 16.200 Remarks: -
Change (%): +4.74 Low: 15.400
Open 15.420 Yesterday's Close 15.200
Buy Price 15.880 Sell Price 15.960
Buy Volume ('000) 5 Sell Volume ('000) 23
Cumulative Volume ('000) 657 Cumulative Value 10,475,260
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -1.01156 Trailing EPS (HKD) e -1.01156 NAV (HKD) b 2.9070
PE a - Trailing PE f - Price / NAV b 5.4764
Dividend (HKD) d - Cash In Hand (HKD) g 0.6675 Issued & Paid-up Shares c 933,465,000
Dividend Yield (%) d - Price / Cash In Hand g 23.850 Treasury Shares h -
Beta - 75 Daysi 0.723 R-Squared - 75 Days(%)i 7.13 Market Cap (M) 14,860.763
Beta - 500 Daysi 0.982 R-Squared - 500 Days (%)i 11.66 Enterprise Value (M) 12,478.984
Piotroski F Score 3 Exchange Code 9966 Par Value ( USD ) n.a.
52 Weeks Volatility (%) n.a. 6-Month VWAP 17.301 Free Float (%) 45.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 21 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 05 Dec 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALPHAMAB-B HKEx 14,860.763 - - 5.4764 -
Industry Biotechnology HKEx 56,925.346 22.296 26.013 6.5752 2.247
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 222,282.746 193.362 193.362 15.5437 -
Local Peer SINO BIOPHARM HKEx 173,439.194 56.509 57.026 5.0060 0.578
Local Peer BEIGENE HKEx 150,149.490 - - 7.6383 -
Local Peer GENSCRIPT BIO HKEx 29,670.397 - - 9.9472 -
Local Peer 3SBIO HKEx 23,222.611 21.033 21.033 2.1569 -
Local Peer HAOHAI BIOTEC HKEx 18,579.639 44.192 44.192 3.1588 0.733
Local Peer VIVA BIOTECH HKEx 18,069.250 59.937 59.936 9.0883 0.173
Local Peer ASCENTAGE-B HKEx 7,758.204 - - 7.7888 -
Local Peer FRONTAGE HKEx 7,584.134 52.513 52.515 3.6785 -
Local Peer KINTOR PHARMA-B HKEx 5,703.382 - - 15.4292 -
Local Peer SINOMAB BIO-B HKEx 3,471.528 - - 2.7418 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx)
Global Peer AMGEN INC NASDAQ 141,573.954 18.053 19.396 13.2821 2.423
Global Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Global Peer GILEAD SCIENCES INC NASDAQ 86,306.085 16.024 - 4.7876 3.697
Global Peer VERTEX PHARMACEUTICAL NASDAQ 70,547.487 59.948 33.904 9.3823 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,149.123 30.792 21.836 7.1929 -
Global Peer ILLUMINA INC NASDAQ 50,244.440 50.144 72.503 11.0113 -
Global Peer BIOGEN INC NASDAQ 46,420.538 7.883 7.832 4.1049 -
Global Peer MODERNA INC NASDAQ 27,431.688 - - 9.3087 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,628.984 - - 15.2303 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,526.601 9.369 26.624 2.1473 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC